E-HOD is a non-exclusive consortium and fosters collaboration among institutions caring for patients with homocystinurias, methylation and remethylation disorders. To become a member a consortial agreement must be signed both by a legal representative of the institution and the member (usually a physician or researcher), who is designated by the institution. For receiving the consortial agreement, please, contact the Chairpersons of E-HOD.
Hospital Universitari Son Espases Ctra Valldemossa
Palma de Mallorca
Hospital Clínico Universitario de Santiago A Choupana
Santiago de Compostela
Hospital Universitario y Politécnico La Fe
Valencia
Hospital Universitario Río Ortega
Valladolid
Switzerland
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne
Kinderspital Zürich
Zurich
Taiwan
National Taiwan University Hospital
Taipei
United Kingdom
Royal Belfast Hospital For Sick Children
Belfast
Bradford Teaching Hospitals NHS Foundation Trust
Bradford
Alder Hey Children’s Hospital NHS Foundation Trust
Liverpool
Guy’s and St Thomas‘s NHS Foundation Trust of Guy’s Hospital
London
University College London Hospitals NHS Foundation Trust
London
Manchester University NHS Foundation Trust
Manchester
Salford Royal NHS foundation Trust
Salford
Sheffield Children's NHS Foundation Trust
Sheffield
USA
The Children’s Hospital of Philadelphia
Philadelphia
Children's National Health System
Washington
This is E-HOD
European network and registry for homocystinurias and methylation defects. Its aim is to improve the health of children, adolescents and adults affected with these rare disorders.
E-HOD has been funded by the European Commission through its Public Health and Consumer Protection Directorate (DG SANCO), PHEA programme (more information).
